NSYSMEDIUM SIGNALFINANCIAL10-K

Nortech Systems showed improved profitability and strengthened cash position while substantially increasing debt levels and capital structure changes.

The company meaningfully reduced losses from the prior year while nearly doubling its cash reserves, suggesting better operational performance and liquidity management. However, the substantial increase in debt levels and current liabilities indicates either growth investments or working capital pressures that warrant monitoring.

Comparing 2026-03-26 vs 2025-03-31View on EDGAR →
FINANCIAL ANALYSIS

Nortech demonstrated notable operational improvement with losses substantially reduced compared to the prior year, while cash reserves grew meaningfully to $1.7M. The company roughly doubled its debt levels to $7.1M and saw current liabilities increase by 39%, alongside moderate growth in accounts receivable. The overall picture suggests improved core performance offset by increased leverage and working capital requirements, with reduced capital expenditures and share buybacks indicating more conservative cash management.

FINANCIAL STATEMENT CHANGES
Total Debt
Balance Sheet
+95.1%
$3.6M$7.1M

Debt increased 95.1% — substantial leverage increase; assess whether deployed for growth or covering losses.

Cash & Equivalents
Balance Sheet
+80.7%
$916K$1.7M

Cash position surged 80.7% — strong cash generation or capital raise providing significant financial cushion.

Net Income
P&L
+80.5%
-$1.3M-$252K

Net income grew 80.5% — bottom-line growth signals improving overall business health.

Share Buybacks
Cash Flow
-52.9%
$276K$130K

Buyback activity reduced 52.9% — capital being redeployed elsewhere or cash conservation underway.

Capital Expenditure
Cash Flow
-48%
$1.3M$661K

Capex reduced 48% — investment cycle winding down or capital discipline; may improve near-term free cash flow.

Current Liabilities
Balance Sheet
+39.3%
$21.4M$29.8M

Current liabilities surged 39.3% — significant near-term obligations; verify ability to meet short-term debt.

Accounts Receivable
Balance Sheet
+14.3%
$14.9M$17.0M

Receivables grew 14.3% — monitor days sales outstanding for collection efficiency.

LANGUAGE CHANGES
NEW — 2026-03-26
PRIOR — 2025-03-31
ADDED
Exhibits and Financial Statement Schedules 55 Signatures 56 Index to Exhibits 57 2 NORTECH SYSTEMS INCORPORATED FORM 10-K For the Year Ended December 31, 2025 PART I Item 1.
Additionally, our facility in Monterrey, Mexico is now certified in AS9100:D.
Food and Drug Administration ( FDA ) registered facility, and our Suzhou operation is National Medical Products Administration certified for class II medical devices.
We seek to develop, in partnership with our customers, a commitment to strong supplier partnerships and risk management tools through advanced supply chain solutions.
4 Major Customers One customer individually accounted for 32.2% of net sales for the year ended December 31, 2025 and 27.7% of net sales for the year ended December 31, 2024.
+7 more — sign up free →
REMOVED
Exhibits and Financial Statement Schedules 53 Signatures 54 Index to Exhibits 55 2 NORTECH SYSTEMS INCORPORATED FORM 10-K For the Year Ended December 31, 2024 PART I Item 1.
Food and Drug Administration ( FDA ) registered facility, and our Suzhou operation is a China National Medical Imaging Administration certified facility.
We attempt to overcome these changes through advanced supply chain solutions we develop in partnership with our customers, a commitment to strong supplier partnerships and risk management tools.
4 Major Customers One customer individually, accounted for at 27.7% of net sales for the year ended December 31, 2024, and two customers, individually, accounted for 25.7% and 10.3%, respectively, of net sales for the year ended December 31, 2023.
We spent approximately $1.2 million on product research and development in each of the years ended December 31, 2024 and 2023.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →